Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06556433 · ClinicalTrials.gov registry record · NA

Family-Based Financial Incentives Intervention for Smoking Cessation

A NA study of Smoking Cessation, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
1,312
Enrollment target
1
Study location

NCT06556433 is a NA study of Smoking Cessation that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 1,312 participants, above the 468-participant average among 188 other Smoking Cessation trials with a reported enrollment target (180% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06556433, a NA study of Smoking Cessation, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
1,312 participants
Enrollment target
1
Study location

Study Summary

The current study will conduct an RCT to evaluate the effectiveness of a family-based incentive intervention with Alaska Native/American Indian families. The experimental arm will be compared to a control arm on biochemically-confirmed smoking abstinence at 6- and 12-months post-intervention.

Conditions Studied

Interventions

  • BEHAVIORAL Financial Incentive Rewards

Study Locations (1)

Alaska

  • Alaska Native Tribal Health Consortium - Anchorage

Trial Details

FieldValue
Enrollment Target 1,312 participants
Start Date 2024-09-03
Est. Completion 2028-04-30
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06556433

The ClinicalTrials.gov registry entry for NCT06556433 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,312 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 468-participant average among 188 other Smoking Cessation trials with a reported enrollment target (180% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Financial Incentive Rewards is the first listed.

NCT06556433 reports 1 study location spanning 1 distinct geographic area - top geographies include Alaska.

Frequently Asked Questions

What is clinical trial NCT06556433 about?

NCT06556433 is a clinical study titled "Family-Based Financial Incentives Intervention for Smoking Cessation". The current study will conduct an RCT to evaluate the effectiveness of a family-based incentive intervention with Alaska Native/American Indian families. The experimental arm will be compared to a control arm on biochemically-confirmed smoking abstinence at 6- and 12-months post-intervention.

What is the current status of trial NCT06556433?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,312 participants. The study started on 2024-09-03. Estimated completion is 2028-04-30.

What conditions does trial NCT06556433 study?

This clinical trial studies the following conditions: Smoking Cessation.

What interventions are being tested in trial NCT06556433?

The interventions under investigation include: Financial Incentive Rewards (BEHAVIORAL).

Who is sponsoring clinical trial NCT06556433?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06556433 being conducted?

This trial has 1 study location across Alaska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.